Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review)
- Authors:
- José Veríssimo Fernandes
- Thales Allyrio Araújo de Medeiros Fernandes
- Jenner Chrystian Veríssimo de Azevedo
- Ricardo Ney Oliveira Cobucci
- Maria Goretti Freire de Carvalho
- Vania Sousa Andrade
- Josélio Maria Galvão de Araújo
-
Affiliations: Department of Microbiology and Parasitology, Federal University of Rio Grande do Norte, Natal 59072‑970, Brazil, Department of Biomedical Sciences, University of Rio Grande do Norte State, Mossoró 59607‑360, Brazil, Department of Pediatrics, University Hospital Onofre Lopes, Federal University of Rio Grande do Norte, Natal 59072‑970, Brazil, Januário Cicco Maternity School, Federal University of Rio Grande do Norte, Natal 59072‑970, Brazil, Department of Pathology, Potiguar University, Natal 59020-500, Brazil - Published online on: January 16, 2015 https://doi.org/10.3892/ol.2015.2884
- Pages: 1015-1026
-
Copyright: © Fernandes et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Ashley NT, Weil ZM and Nelson RJ: Inflammation: mechanisms, costs, and natural variation. Ann Rev Ecol Evol Syst. 43:385–406. 2012. View Article : Google Scholar | |
Medzhitov R: Origin and physiological roles of inflammation. Nature. 454:428–435. 2008. View Article : Google Scholar : PubMed/NCBI | |
Graham BS: Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunol Rev. 239:149–166. 2011. View Article : Google Scholar : PubMed/NCBI | |
Martinon F, Mayor A and Tschopp J: The inflammasomes: guardians of the body. Annu Rev Immunol. 27:229–265. 2009. View Article : Google Scholar : PubMed/NCBI | |
Nathan C: Points of control in inflammation. Nature. 420:846–852. 2002. View Article : Google Scholar : PubMed/NCBI | |
Adefuye A and Sales K: Regulation of inflammatory pathways in cancer and infectious disease of the cervix. Scientifica (Cairo). 2012:5481502012. | |
Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI | |
Schottenfeld D and Beebe-Dimmer JL: Advances in cancer epidemiology: understanding causal mechanisms and the evidence for implementing interventions. Ann Rev Public Health. 26:37–60. 2005. View Article : Google Scholar | |
Akagi K, Li J, Broutian TR, Padilla-Nash H, et al: Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res. 24:185–199. 2014. View Article : Google Scholar : | |
Trottier H and Franco EL: The epidemiology of genital human papillomavirus infection. Vaccine. 24(Suppl 1): S1–S15. 2006. View Article : Google Scholar : PubMed/NCBI | |
Muñoz N, Castellsagué X, de González AB and Gissmann L: Chapter 1: HPV in the etiology of human cancer. Vaccine. 24(Suppl 3): S1–S10. 2006. View Article : Google Scholar | |
Mazibrada J, Rittà M, Mondini M, et al: Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol. 108:112–120. 2008. View Article : Google Scholar | |
Paghini BC, Abdalla DR, Barcelos AC, et al: Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia. Hum Immunol. 73:920–926. 2012. View Article : Google Scholar | |
Graham CS, Wells A, Liu T, et al: Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS. 19:767–773. 2005. View Article : Google Scholar : PubMed/NCBI | |
Tang T, Wong HK, Gu W, et al: MicroRNA-182 plays an onco-miRNA role in cervical cancer. Gynecol Oncol. 129:199–208. 2013. View Article : Google Scholar : PubMed/NCBI | |
Viviani B, Bartesaghi S, Gardoni F, et al: Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci. 23:8692–8700. 2003.PubMed/NCBI | |
Pasparakis M: Regulation of tissue homeostasis by NF-kappaB signaling: implications for inflammatory diseases. Nat Rev Immunol. 9:778–788. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lou JL, Maeda S, Hsu LC, et al: Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell. 6:297–305. 2004. View Article : Google Scholar | |
Hussain SP, Hofseth LJ and Harris CC: Radical causes of cancer. Nat Rev Cancer. 3:276–285. 2003. View Article : Google Scholar : PubMed/NCBI | |
Chen WL and Konkel JE: TGF-beta and ‘adaptive’ Foxp3(+) regulatory T cells. J Mol Cell Biol. 2:30–36. 2010. View Article : Google Scholar : | |
Derynck R, Akhurst RJ and Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 29:117–129. 2001. View Article : Google Scholar : PubMed/NCBI | |
Ishihara K and Hirano T: Il-6 autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13:357–368. 2002. View Article : Google Scholar : PubMed/NCBI | |
Jenkins BJ, Roberts AW, Greenhill CJ, et al: Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. Blood. 109:2380–2388. 2007. View Article : Google Scholar | |
Vicari AP and Trinchieri G: Interleukin-10 in viral diseases and cancer: exiting the labyrinth? Immunol Rev. 202:223–236. 2004. View Article : Google Scholar : PubMed/NCBI | |
Mocellin S, Marincola FM and Young HA: Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol. 78:1043–1051. 2005. View Article : Google Scholar : PubMed/NCBI | |
Sadler AJ and Williams BR: Interferon-inducible antiviral effectors. Nature Rev Immunol. 8:559–568. 2008. View Article : Google Scholar | |
González-Navajas JM, Lee J, David M and Raz E: Immunomodulatory functions of type I interferons. Nat Rev Immunol. 12:125–135. 2012.PubMed/NCBI | |
Guarda G, Braun M, Staehli F, et al: Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity. 34:213–223. 2011. View Article : Google Scholar : PubMed/NCBI | |
Schroder K, Hertzog PJ, Ravasi T and Hume DA: Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 75:163–189. 2004. View Article : Google Scholar | |
Schoenborn JR and Wilson CB: Regulation of Interferon-gamma during innate and adaptive immune responses. Adv Immunol. 96:41–101. 2007. View Article : Google Scholar : PubMed/NCBI | |
Ruddy MJ, Wong GC, Liu XK, et al: Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem. 279:2559–2567. 2004. View Article : Google Scholar | |
Zhang Y, Ma D, Zhang Y, et al: The imbalance of Th17/Treg in patients with uterine cervical cancer. Clin Chim Acta. 412:894–900. 2011. View Article : Google Scholar : PubMed/NCBI | |
Chen Z, Ding J, Pang N, et al: The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients. Diagn Pathol. 8:612013. View Article : Google Scholar : PubMed/NCBI | |
Cho ML, Kang JW, Moon YM, et al: STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol. 176:5652–5661. 2006. View Article : Google Scholar : PubMed/NCBI | |
Hao JS and Shan BE: Immune enhancement and anti-tumour activity of IL-23. Cancer Immunol Immunother. 55:1426–1431. 2006. View Article : Google Scholar : PubMed/NCBI | |
Biet F, Locht C and Kremer L: Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med (Berl). 80:147–162. 2002. View Article : Google Scholar | |
Nakanishi K: Regulation of Th1 and Th2 immune responses by IL-18. Kekkaku. 77:87–93. 2002.(Japanese). PubMed/NCBI | |
Reddy P and Ferrara JL: Role of interleukin-18 in acute graft-vs-host disease. J Lab Clin Med. 141:365–371. 2003. View Article : Google Scholar : PubMed/NCBI | |
Medzhitov R: Origin and physiological roles of inflammation. Nature. 454:428–435. 2008. View Article : Google Scholar : PubMed/NCBI | |
Serhan CN and Savill J: Resolution of inflammation: the beginning programs the end. Nat Immunol. 6:1191–1197. 2005. View Article : Google Scholar : PubMed/NCBI | |
Akira S, Uematsu S and Takeuchi O: Pathogen recognition and innate immunity. Cell. 124:783–801. 2006. View Article : Google Scholar : PubMed/NCBI | |
Mogensen TH: Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 22:240–273. 2009. View Article : Google Scholar : PubMed/NCBI | |
Roach JC, Glusman G, Rowen L, et al: The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci USA. 102:9577–9582. 2005. View Article : Google Scholar : PubMed/NCBI | |
Proell M, Riedl SJ, Fritz JH, et al: The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One. 3:e21192008. View Article : Google Scholar : PubMed/NCBI | |
Friedman R and Hughes AL: Molecular evolution of the NF-kappaB signaling system. Immunogenetics. 53:964–974. 2002. View Article : Google Scholar : PubMed/NCBI | |
Ahmed AU: An overview of inflammation: mechanism and consequences. Front Biol. 6:274–281. 2011. | |
Welsh RM, Bahl K, Marshall HD and Urban SL: Type 1 interferons and antiviral CD8 T-Cell responses. PLoS Pathog. 8:e10023522012. View Article : Google Scholar : PubMed/NCBI | |
Sica A and Bronte V: Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest. 117:1155–1166. 2007. View Article : Google Scholar : PubMed/NCBI | |
Liu CY, Xu JY, Shi XY, et al: M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Invest. 93:844–854. 2013. View Article : Google Scholar : PubMed/NCBI | |
Lin WW and Karin M: A cytokine-mediated link between innate immunity, inflammation and cancer. J Clin Invest. 117:1175–1183. 2007. View Article : Google Scholar : PubMed/NCBI | |
Sieve AN, Meeks KD, Lee S and Berg RE: A novel immunoregulatory function for IL-23: inhibition of IL-12-dependent IFN-γ production. Eur J Immunol. 40:2236–2247. 2010. View Article : Google Scholar : PubMed/NCBI | |
Rubtsov YP, Rasmussen JP, Chi EY, et al: Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 28:546–558. 2008. View Article : Google Scholar : PubMed/NCBI | |
Ouyang W, Kolls JK and Zheng Y: The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 28:454–467. 2008. View Article : Google Scholar : PubMed/NCBI | |
Koch MA, Trucker-Heard G, Perduc NR, et al: The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol. 10:595–602. 2009. View Article : Google Scholar : PubMed/NCBI | |
Anthony MN, Gardner L, Marks G, et al: Factors associated with use of HIV primary care among persons recently diagnosed with HIV: examination of variables from the behavioural model of health-care utilization. AIDS Care. 19:195–202. 2007. View Article : Google Scholar : PubMed/NCBI | |
Anthony RM, Rutitzky LI, Urban JF Jr, Stadecker MJ and Gause WC: Protective immune mechanisms in helminth infection. Nat Rev Immunol. 7:975–987. 2007. View Article : Google Scholar : PubMed/NCBI | |
Graham AL: When T-helper cells don’t help: immunopathology during concomitant infection. Q Rev Biol. 77:409–434. 2002. View Article : Google Scholar | |
Suvas S, Azkur AK, Kim BS, et al: CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol. 172:4123–4132. 2004. View Article : Google Scholar : PubMed/NCBI | |
Belkaid Y and Tarbell K: Regulatory T Cells in the Control of host-microorganism interactions. Ann Rev Immunol. 27:551–589. 2009. View Article : Google Scholar | |
Korn T, Bettelli E, Oukka M and Kuchroo VK: IL-17 and Th17 cells. Ann Rev Immunol. 27:485–517. 2009. View Article : Google Scholar | |
Jabbour HN, Sales KJ, Catalano RD and Norman JE: Inflammatory pathways in female reproductive health and disease. Reproduction. 138:903–919. 2009. View Article : Google Scholar : PubMed/NCBI | |
Maeda K, Yoshida K, Ichimiya I and Suzuki M: Dexamethasone inhibits tumor necrosis factor-alpha-induced cytokine secretion from spiral ligament fibrocytes. Hear Res. 202:154–160. 2005. View Article : Google Scholar : PubMed/NCBI | |
Sakurai F, Nakamura S, Akitomo K, Shibata H, et al: Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates. Mol Ther. 16:726–733. 2008. View Article : Google Scholar : PubMed/NCBI | |
Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar : PubMed/NCBI | |
Karin M and Greten FR: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 5:749–759. 2005. View Article : Google Scholar : PubMed/NCBI | |
Karin M: Nuclear factor-kappaB in cancer development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI | |
Karin M: NF-kappaB and cancer: mechanisms and targets. Mol Carcinog. 45:355–361. 2006. View Article : Google Scholar : PubMed/NCBI | |
Karin M, Cao Y, Greten FR and Li ZW: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2:301–310. 2002. View Article : Google Scholar : PubMed/NCBI | |
Lou L, Li DQ, Corrales RM and Pflugfelder SC: Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens. 31:186–193. 2005. View Article : Google Scholar | |
Parkin DM and Bray F: Chapter 2: The burden of HPV-related cancers. Vaccine. 24(Suppl 3): S11–S25. 2006. View Article : Google Scholar | |
Shukla S, Bharti AC, Mahata S, et al: Infection of human papillomavirus in cancers of different human organ sites. Indian J Med Res. 130:222–233. 2009.PubMed/NCBI | |
Moody CA and Laimins LA: Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 10:550–560. 2010. View Article : Google Scholar : PubMed/NCBI | |
Fernandes JV, Araújo JMG and Fernandes TAAM: Biology and natural history of human papillomavirus infection. Open Access J Clin Trials. 5:1–12. 2013. View Article : Google Scholar | |
Hernádi Z, Gazdag L, Szoke K, Sápy T, Krasznai ZT and Kónya J: Duration of HPV-associated risk for high-grade cervical intraepithelial neoplasia. Eur J Obstet Gynecol Reprod Biol. 125:114–119. 2006. View Article : Google Scholar | |
Fernandes JV, Fernandes TAAM and de Araújo JMG: Human papillomavirus infection in adolescents. Handbook on Human Papillomavirus: Prevalence, Detection & Management. Smith HB: Nova Science Publishers; New York, NY: pp. 181–212. 2013 | |
Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI | |
Stanley M: Immune responses to human papillomavirus. Vaccine. 24(Suppl 1): S16–S22. 2006. View Article : Google Scholar | |
Smith JS, Herrero R, Bosetti C, et al: Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst. 94:1604–1613. 2002. View Article : Google Scholar : PubMed/NCBI | |
Smith JS, Muñoz N, Herrero R, et al: Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis. 185:324–331. 2002. View Article : Google Scholar : PubMed/NCBI | |
de Abreu AL, Nogara PR, Souza RP, et al: Molecular detection of HPV and Chlamydia trachomatis infections in Brazilian women with abnormal cervical cytology. Am J Trop Med Hyg. 87:1149–1151. 2012. View Article : Google Scholar : PubMed/NCBI | |
Scott M, Stites DP and Mosciki AB: Th1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol. 6:751–755. 1999.PubMed/NCBI | |
Adefuye A and Sales K: Regulation of inflammatory pathways in cancer and infectious disease of the cervix. Scientifica (Cairo). 2012:5481502012. | |
Ambros V and Chen X: The regulation of genes and genomes by small RNAs. Development. 134:1635–1641. 2007. View Article : Google Scholar : PubMed/NCBI | |
Niwa R and Slack FJ: The evolution of animal microRNA function. Curr Opin Genet Dev. 17:145–150. 2007. View Article : Google Scholar : PubMed/NCBI | |
Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009. View Article : Google Scholar : PubMed/NCBI | |
Tili E, Michaillle JJ and Croce CM: MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol Rev. 253:167–184. 2013. View Article : Google Scholar : PubMed/NCBI | |
Trotta R, Chen L, Ciarlariello D, et al: miR-155 regulates IFN-γ production in natural killer cells. Blood. 119:3478–3485. 2012. View Article : Google Scholar : PubMed/NCBI | |
Schetter AJ, Okayama H and Harris CC: The role of microRNAs in colorectal cancer. Cancer J. 18:244–252. 2012. View Article : Google Scholar : PubMed/NCBI | |
de Visser KE, Korets LV and Coussens LM: De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell. 7:411–423. 2005. View Article : Google Scholar : PubMed/NCBI | |
Viau M and Zouali M: B-lymphocytes, innate immunity, and autoimmunity. Clin Immunol. 114:17–26. 2005. View Article : Google Scholar | |
Balkwill F, Charies KA and Mantovani A: Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 7:211–217. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hawes SE and Kiviat NB: Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer? J Natl Cancer Inst. 94:1592–1593. 2002. View Article : Google Scholar : PubMed/NCBI | |
Schwebke JR and Zajackowski ME: Effect of concurrent lower genital tract infections on cervical cancer screening. Genitourin Med. 73:383–386. 1997. | |
Castle PE, Hillier SL, Rabe LK, et al: An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev. 10:1021–1027. 2001.PubMed/NCBI | |
Yang YC, Chang CL, Huang YW and Wang DY: Possible cofactor in cervical carcinogenesis: proliferation index of the transformation zone in cervicitis. Chang Gung Med J. 24:615–620. 2001. | |
Hammes LS, Tekmal RR, Naud P, et al: Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression - clinicopathological correlation. Gynecol Oncol. 105:157–165. 2007. View Article : Google Scholar : PubMed/NCBI | |
Kovacic MB, Katki HA, Kreimer AR and Sherman ME: Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections. Human Pathol. 39:1088–1095. 2008. View Article : Google Scholar | |
Sharkey DJ, Tremellen KP, Jasper MJ, et al: Seminal fluid Induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol. 188:2445–2454. 2012. View Article : Google Scholar : PubMed/NCBI | |
Manhart LS and Koutsky LZ: Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis. 29:725–735. 2002. View Article : Google Scholar : PubMed/NCBI | |
Sales KJ and Jabbour HN: Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. Prostaglandins Other Lipid Mediat. 71:97–117. 2003. View Article : Google Scholar : PubMed/NCBI | |
Silva J: Cerqueira F and Medeiros R: Chlamydia trachomatis infection: implications for HPV status and cervical cancer. Arch Gynecol Obstet. 289:715–23. 2014. View Article : Google Scholar | |
Niebler M, Quian X, Höfler D, et al: Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53. PLOS Pathog. 9:e10035362013. View Article : Google Scholar | |
Kemp TJ, Hildesheim A, Garcia-Piñeres A, et al: Elevated systemic levels of inflammatory cytokines in older women with persistent cervical HPV infection. Cancer Epidemiol Biomarkers Prev. 19:1954–1959. 2010. View Article : Google Scholar : PubMed/NCBI | |
Kaul R and Hirbod T: Editorial: Genital epithelial cells: foot soldiers or fashion leaders? J Leuk Biol. 88:427–429. 2010. View Article : Google Scholar | |
Stanley M: Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 117(Suppl 2): S5–S10. 2010. View Article : Google Scholar | |
Karim R, Tummers B, Meyers C, et al: Human papillomavirus (HPV) upregulates t6he cellular deubiquitinase UCHL1 to suppress the keratinocyte’s innate immune response. PLOS Pathog. 9:e10033842013. View Article : Google Scholar | |
Senba M and Mori N: Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. Oncol Rev. 6:135–144. 2012. View Article : Google Scholar | |
Senba M, Buziba N, Mori N, et al: Human papillomavirus infection induces NF-κB activation in cervical cancer: a comparison with penile cancer. Oncol Lett. 2:65–68. 2011.PubMed/NCBI | |
James MA, Lee JH and Klingelhutz AJ: Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J Virol. 80:5301–5307. 2006. View Article : Google Scholar : PubMed/NCBI | |
Scott ME, Shvetsov YB, Thompson PJ, et al: Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study. Int J Cancer. 133:1187–1196. 2013. View Article : Google Scholar : PubMed/NCBI | |
Broccardo E, Lepique AP and Villa LL: The role of inflammation in HPV carcinogenesis. Carcinogenesis. 31:1905–1912. 2010. View Article : Google Scholar | |
Balkwill F: Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 13:135–41. 2002. View Article : Google Scholar : PubMed/NCBI | |
Stanley MA, Pett MR and Coleman N: HPV: from infection to cancer. Bioch Soc Trans. 35:1456–1460. 2007. View Article : Google Scholar | |
Tindle RW: Immune evasion in human papillomavirus-associated cervical cancer. Nature Rev Cancer. 2:59–65. 2002. View Article : Google Scholar | |
zur Hausen H: Papillomaviruses in the causation of human cancers - a brief historical account. Virology. 384:260–265. 2009. View Article : Google Scholar : PubMed/NCBI | |
Oh JM, Kim SH, Lee YI, et al: Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells. Carcinogenesis. 30:144–149. 2009. | |
Bodily J and Laimins LA: Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol. 19:33–39. 2011. View Article : Google Scholar : | |
Trinchieri G: Innate inflammation and cancer: is it time for cancer prevention? F1000 Med Rep. 3:112011. View Article : Google Scholar : PubMed/NCBI | |
Sales KJ, Katz AA, Howard B, et al: Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res. 62:424–432. 2002.PubMed/NCBI | |
Santin AD, Zhan F, Bignotti E, et al: Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virol. 331:269–291. 2005. View Article : Google Scholar |